No Data
No Data
No Data
No Data
No Data
One Athira Pharma Insider Raised Their Stake In The Previous Year
Yahoo FinanceApr 23 09:28 ET
Express News | Athira Pharma Appoints Javier San Martin, M.d., as Chief Medical Officer
Moomoo 24/7Apr 15 07:00 ET
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease
Key findings reported in the study publication regarding fosgonimeton in preclinical models of Alzheimer's disease include:In primary rat cortical neurons challenged with Aβ, fosgonimeton treatment im
BenzingaApr 11 07:09 ET
Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?
Yahoo FinanceMar 29 09:40 ET
ANGI, MLKN and KOD Are Among After Hour Movers
Seeking AlphaMar 27 16:50 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAvalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 215.8% to $15.0 during Wednesday's after-market session. The market value of their outstanding shares is at $12.0 million. Fresh2 Group
BenzingaMar 27 16:31 ET
AmyNic : Looking at the weekly I don't think its ready to break out of the falling wedge just yet. imo it will come up some more and reject at the trendline. Its in a bear flag within the wedge. I think it may have a little more downside. Definitely worth watching and an opportunity to get some gains before the next drop. Keep in mind the higher the timeframe the bigger the move and the longer it takes.
AmyNic : Here's a zoomed out look at the wedge
JP88OP : Thanks! I definitely wasn't thinking of going very long on it, possibly a few week swing if anything. I'll keep an eye on it.
warmhearted Puppy_93 : Check out BTBT on Webull .$
Mcsnacks H Tupack : It's out of steam. Going to downtrend
Moomoo Breakfast USOP : Is our column helping your daily trading?
No Data
No Data